Novo Nordisk v. Caraco Pharmaceutical Laboratories

U.S. Court of Appeals for the Federal Circuit

Novo Nordisk v. Caraco Pharmaceutical Laboratories

Opinion

NOTE: This order is nonprecedential.

Wniteb ~tate5 qcourt of §ppeaI5 for tbe jfeberaI qcircuit

NOVO NORDISK AlS AND NOVO NORDISK INC., Plaintiffs-Appellants, v. CARACO PHARMACEUTICAL LABORATORIES, LTD. AND SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellees.

2011-1223

Appeal from the United States District Court for the Eastern District of Michigan in case no. 05-CV-40188, Judge Avern Cohn.

NOVO NORDISK INC. AND NOVO NORDISK AlS, Plaintiffs-Appellants, v. PADDOCK LABORATORIES, INC., Defendant-Appellee. NOVO NORDISK V. PADDOCK LABS 2

2012-1031

Appeal from the United States District Court for the District of Minnesota in case no. 10-CV-2199, Judge Donovan W. Frank.

ON MOTION

ORDER Novo Nordisk et al. submit responses and motions concerning how these cases should proceed. Upon consideration thereof, IT Is ORDERED THAT:

(1) The motions are granted to the extent that the stays of the briefing schedules are lifted in the two above- captioned appeals. The appellant's opening brief in each appeal is due within 40 days of the date of filing of this order. (2) Appeal 2011-1223 and 2012-1031 will be treated as companion cases, i.e., they will be argued consecutively before the same merits panel. FOR THE COURT AUG 15 2012 /s/ Jan Horbaly Date Jan Horbaly Clerk cc: Daniel G. Brown, Esq. James F. Hurst, Esq. Mark A. Perry, Esq. s8 u.s. eoUJt~~PEAlS FOR THE FEDERAL CIRCUIT AUG 15 201l JAN HORBALY CLERK

Reference

Status
Unpublished